A dipeptide-based hydrogel that self-assembles under body conditions showed antibacterial activity against Staph and Bacillus, biocompatibility, and effective wound healing in mice.
Self-assembles at body conditionsThe dipeptide-cyclodextrin hydrogel forms spontaneously at pH 7.4 and 37°C, creating antibacterial nanofiber networks that heal wounds in vivo
What the researchers found
An Amoc-capped dipeptide co-assembled with β-cyclodextrin under physiological conditions (pH 7.4, 37°C) to form a self-supporting hydrogel with entangled nanofibrillar networks.
The hydrogel demonstrated:
- Inherent antibacterial activity against Gram-positive bacteria Bacillus subtilis and Staphylococcus aureus
- Mechanism of killing: aggregation-induced membrane permeabilization and rupture (confirmed by SEM)
- Shear-thinning behavior enabling easy application
- Biocompatibility with HEK293 and AGS cell lines
- In vivo wound healing confirmed by digital photography and histopathological analysis
- Anti-inflammatory activity via reduction of nitrite levels during healing
Why it matters
Chronic wounds and antibiotic-resistant infections are growing healthcare challenges. A wound dressing that inherently kills bacteria without traditional antibiotics — while also promoting healing and reducing inflammation — could help address both problems simultaneously, especially as antibiotic resistance continues to rise.
How the study worked
The hydrogel was prepared by co-assembling Amoc-capped dipeptide with β-cyclodextrin at physiological pH and temperature. Characterization included electron microscopy (nanostructure), rheology (mechanical properties), and shear-thinning tests. Antibacterial activity was tested against B. subtilis and S. aureus with SEM imaging of bacterial damage. Biocompatibility was assessed with HEK293 and AGS cell lines. In vivo wound healing was evaluated in mice through photographic monitoring and histopathological analysis.
What this study cannot tell us
Only Gram-positive bacteria were tested; activity against Gram-negative bacteria (which cause many wound infections) was not reported. The mouse wound model may not fully represent human wound healing, particularly for chronic or diabetic wounds. Long-term stability and shelf life of the hydrogel were not assessed. Manufacturing scalability was not addressed.
How to read the evidence
This study includes both in vitro and in vivo (mouse) evidence, placing it at a moderate preclinical evidence level. The combination of antibacterial, biocompatibility, and wound healing data is comprehensive for a materials science study.
When this study was published
Published in 2025, this study represents current work in the rapidly advancing field of peptide-based biomaterials for wound care applications.
The bigger picture
This study exemplifies the growing field of peptide-based biomaterials, where short peptides self-assemble into functional materials with built-in biological activity. Unlike traditional wound dressings that merely cover wounds, these smart materials can actively fight infection, reduce inflammation, and promote healing — moving wound care from passive protection to active therapy.
Questions still open
- Does this hydrogel also work against Gram-negative bacteria and antibiotic-resistant strains like MRSA?
- How does wound healing performance compare to existing commercial wound dressings?
- Can the hydrogel be loaded with additional drugs for enhanced therapeutic effects?
Common questions
How does a peptide hydrogel kill bacteria?
What makes self-assembling peptide hydrogels special for wound care?
Read the original research
Antibacterial efficacy of a peptide co-assembled hydrogel matrix for wound care.
International journal of biological macromolecules, 331(Pt 2), 148388
Citation
Gavel, Pramod K; Rit, Tanmay; Bagde, Pranit Hemant; Parmar, Hamendra S; Jha, Hem Chandra; Das, Apurba K. (2025). Antibacterial efficacy of a peptide co-assembled hydrogel matrix for wound care.. International journal of biological macromolecules, 331(Pt 2), 148388. https://doi.org/10.1016/j.ijbiomac.2025.148388